Dianthus Therapeutics Stock Forecast - Naive Prediction
| DNTH Stock | 41.83 1.32 3.06% |
The Naive Prediction forecasted value of Dianthus Therapeutics on the next trading day is expected to be 43.35 with a mean absolute deviation of 0.95 and the sum of the absolute errors of 59.05. Dianthus Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Dianthus Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
The current Inventory Turnover is estimated to decrease to 0.14. The current Payables Turnover is estimated to decrease to 0.09. The Dianthus Therapeutics' current Common Stock Shares Outstanding is estimated to increase to about 35 M, while Net Loss is projected to decrease to (26.9 M). Open Interest Against 2026-02-20 Dianthus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Dianthus Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Dianthus Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Dianthus Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Dianthus Therapeutics' open interest, investors have to compare it to Dianthus Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Dianthus Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Dianthus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Dianthus Therapeutics Cash Forecast
Predicting cash flow or other financial metrics requires analysts to utilize a variety of statistical methods, techniques, and algorithms. These tools help uncover hidden patterns in the Dianthus Therapeutics' financial statements, enabling forecasts of their impact on future stock prices.
Cash | First Reported 2017-12-31 | Previous Quarter 13.2 M | Current Value 56 M | Quarterly Volatility 77.8 M |
Dianthus Therapeutics Naive Prediction Price Forecast For the 28th of December
Given 90 days horizon, the Naive Prediction forecasted value of Dianthus Therapeutics on the next trading day is expected to be 43.35 with a mean absolute deviation of 0.95, mean absolute percentage error of 1.40, and the sum of the absolute errors of 59.05.Please note that although there have been many attempts to predict Dianthus Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dianthus Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dianthus Therapeutics Stock Forecast Pattern
| Backtest Dianthus Therapeutics | Dianthus Therapeutics Price Prediction | Buy or Sell Advice |
Dianthus Therapeutics Forecasted Value
In the context of forecasting Dianthus Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Dianthus Therapeutics' downside and upside margins for the forecasting period are 40.04 and 46.65, respectively. We have considered Dianthus Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Dianthus Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Dianthus Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.2813 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.9524 |
| MAPE | Mean absolute percentage error | 0.025 |
| SAE | Sum of the absolute errors | 59.0508 |
Predictive Modules for Dianthus Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dianthus Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dianthus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Dianthus Therapeutics
For every potential investor in Dianthus, whether a beginner or expert, Dianthus Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dianthus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dianthus. Basic forecasting techniques help filter out the noise by identifying Dianthus Therapeutics' price trends.Dianthus Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dianthus Therapeutics stock to make a market-neutral strategy. Peer analysis of Dianthus Therapeutics could also be used in its relative valuation, which is a method of valuing Dianthus Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dianthus Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Dianthus Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Dianthus Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dianthus Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dianthus Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dianthus Therapeutics shares will generate the highest return on investment. By undertsting and applying Dianthus Therapeutics stock market strength indicators, traders can identify Dianthus Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 14268.52 | |||
| Daily Balance Of Power | (0.68) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 42.43 | |||
| Day Typical Price | 42.23 | |||
| Price Action Indicator | (1.26) | |||
| Period Momentum Indicator | (1.32) |
Dianthus Therapeutics Risk Indicators
The analysis of Dianthus Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dianthus Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dianthus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.23 | |||
| Semi Deviation | 2.39 | |||
| Standard Deviation | 3.39 | |||
| Variance | 11.51 | |||
| Downside Variance | 6.86 | |||
| Semi Variance | 5.72 | |||
| Expected Short fall | (2.87) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Historical Fundamental Analysis of Dianthus Therapeutics to cross-verify your projections. For more detail on how to invest in Dianthus Stock please use our How to Invest in Dianthus Therapeutics guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dianthus Therapeutics. If investors know Dianthus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dianthus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.50) | Revenue Per Share | Quarterly Revenue Growth (0.82) | Return On Assets | Return On Equity |
The market value of Dianthus Therapeutics is measured differently than its book value, which is the value of Dianthus that is recorded on the company's balance sheet. Investors also form their own opinion of Dianthus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dianthus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dianthus Therapeutics' market value can be influenced by many factors that don't directly affect Dianthus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dianthus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dianthus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dianthus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.